Orphapacket:
  Children:
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '12405'
            Source: HGNC
          - Reference: '176300'
            Source: OMIM
          Label: transthyretin
          Symbol: TTR
      Label: ATTRV30M amyloidosis
      ORPHAcode: '85447'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '12405'
            Source: HGNC
          - Reference: '176300'
            Source: OMIM
          Label: transthyretin
          Symbol: TTR
      Label: ATTRV122I amyloidosis
      ORPHAcode: '85451'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '105210'
    Source: OMIM
  Label: Hereditary ATTR amyloidosis
  ORPHAcode: '271861'
  ORPHApacketId: '271861'
  PURL: http://www.orpha.net/ORDO/Orphanet_271861
  Parents:
  - Parent:
    - Label: Amyloidosis
      ORPHAcode: '69'
  - Parent:
    - Label: Rare disorder with progressive vitreoretinopathy disorder as a major
        feature
      ORPHAcode: '716446'
  - Parent:
    - Label: Familial restrictive cardiomyopathy
      ORPHAcode: '217635'
  - Parent:
    - Label: Hereditary amyloidosis
      ORPHAcode: '444116'
  - Parent:
    - Label: Rare disorder potentially indicated for liver transplant
      ORPHAcode: '506210'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002019
      HPOTerm: Constipation
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002578
      HPOTerm: Gastroparesis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003202
      HPOTerm: Skeletal muscle atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0004926
      HPOTerm: Orthostatic hypotension due to autonomic dysfunction
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007141
      HPOTerm: Sensorimotor neuropathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0011675
      HPOTerm: Arrhythmia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012185
      HPOTerm: Constrictive median neuropathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012332
      HPOTerm: Abnormal autonomic nervous system physiology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012722
      HPOTerm: Heart block
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0031327
      HPOTerm: Transthyretin cardiac amyloidosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100832
      HPOTerm: Vitreous floaters
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000083
      HPOTerm: Renal insufficiency
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000100
      HPOTerm: Nephrotic syndrome
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001324
      HPOTerm: Muscle weakness
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004610
      HPOTerm: Lumbar spinal canal stenosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0009027
      HPOTerm: Foot dorsiflexor weakness
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010829
      HPOTerm: Impaired temperature sensition
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0011970
      HPOTerm: Cerebral amyloid angiopathy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012531
      HPOTerm: Pain
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025309
      HPOTerm: Abnormal pupil shape
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0031006
      HPOTerm: Acroparesthesia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0031189
      HPOTerm: Wrist drop
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0033748
      HPOTerm: Hypoesthesia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100550
      HPOTerm: Tendon rupture
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000016
      HPOTerm: Urinary retention
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000112
      HPOTerm: Nephropathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000501
      HPOTerm: Glaucoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000802
      HPOTerm: Impotence
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000970
      HPOTerm: Anhidrosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001097
      HPOTerm: Keratoconjunctivitis sicca
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001635
      HPOTerm: Congestive heart failure
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001712
      HPOTerm: Left ventricular hypertrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001723
      HPOTerm: Restrictive cardiomyopathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002014
      HPOTerm: Diarrhea
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002017
      HPOTerm: Nausea and vomiting
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Argentina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bangladesh
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cyprus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Ecuador
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Hungary
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: India
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Israel
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Romania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Russian Federation
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sri Lanka
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Lifetime Prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Luxembourg
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Malaysia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Mexico
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: New Zealand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 29211930[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: Familial TTR-related amyloidosis
  - Synonym: Familial transthyretin-related amyloidosis
  - Synonym: Hereditary transthyretin amyloid polyneuropathy
  - Synonym: Hereditary TTR amyloid polyneuropathy
  - Synonym: Hereditary TTR amyloidosis
  - Synonym: ATTRv amyloidosis
  - Synonym: hATTR
  TextSection:
    Contents: A rare genetic systemic disease characterized by adult onset progressive
      sensorimotor and autonomic neuropathy and infiltrative cardiomyopathy. Neurological
      involvement usually starts with sensory loss in the extremities and progresses
      with motor neuropathy. Cardiomyopathy presents with rhythm abnormalities and
      heart failure. The disease also frequently manifests with a range of additional
      clinical signs and symptoms due to associated ocular renal central nervous system
      and gastrointestinal involvement.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Autosomal dominant
  copyright: Orphanet (c) 2025
  creationDate: '2025-12-09 10:41:42'
  version: 1.3.42 / 4.1.8 [2025-03-03]
